Inspire Medical Systems Stock Net Income
| INSP Stock | USD 186.19 1.42 0.77% |
Inspire Medical Systems fundamentals help investors to digest information that contributes to Inspire Medical's financial success or failures. It also enables traders to predict the movement of Inspire Stock. The fundamental analysis module provides a way to measure Inspire Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Inspire Medical stock.
| Last Reported | Projected for Next Year | ||
| Net Loss | -32.8 M | -34.4 M | |
| Net Loss | -40.4 M | -42.4 M | |
| Net Loss | -21.2 M | -22.2 M | |
| Net Loss | (0.72) | (0.76) | |
| Net Income Per E B T | 1.06 | 0.82 |
Inspire | Net Income |
Inspire Medical Systems Company Net Income Analysis
Inspire Medical's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Inspire Medical Net Income | (21.15 M) |
Most of Inspire Medical's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Inspire Medical Systems is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Inspire Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Inspire Medical is extremely important. It helps to project a fair market value of Inspire Stock properly, considering its historical fundamentals such as Net Income. Since Inspire Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Inspire Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Inspire Medical's interrelated accounts and indicators.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Inspire Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Inspire Medical Systems reported net income of (21.15 Million). This is 106.2% lower than that of the Health Care Technology sector and 108.88% lower than that of the Health Care industry. The net income for all United States stocks is 103.7% higher than that of the company.
Inspire Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Inspire Medical's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Inspire Medical could also be used in its relative valuation, which is a method of valuing Inspire Medical by comparing valuation metrics of similar companies.Inspire Medical is currently under evaluation in net income category among its peers.
Inspire Medical Current Valuation Drivers
We derive many important indicators used in calculating different scores of Inspire Medical from analyzing Inspire Medical's financial statements. These drivers represent accounts that assess Inspire Medical's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Inspire Medical's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 1.8B | 4.9B | 6.3B | 7.1B | 6.0B | 6.3B | |
| Enterprise Value | 1.8B | 4.7B | 6.1B | 6.6B | 5.8B | 6.1B |
Inspire Medical ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Inspire Medical's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Inspire Medical's managers, analysts, and investors.Environmental | Governance | Social |
Inspire Medical Institutional Holders
Institutional Holdings refers to the ownership stake in Inspire Medical that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Inspire Medical's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Inspire Medical's value.| Shares | Artisan Partners Limited Partnership | 2024-06-30 | 544.7 K | Amvescap Plc. | 2024-06-30 | 539.1 K | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 514.8 K | Geode Capital Management, Llc | 2024-06-30 | 480.5 K | Hhg Plc | 2024-06-30 | 475.2 K | Champlain Investment Partners, Llc | 2024-09-30 | 464.6 K | Frontier Capital Management Co Inc | 2024-09-30 | 395 K | Ubs Asset Mgmt Americas Inc | 2024-09-30 | 365.2 K | T. Rowe Price Associates, Inc. | 2024-06-30 | 364.9 K | Vanguard Group Inc | 2024-09-30 | 3.2 M | Fmr Inc | 2024-09-30 | 2.9 M |
Inspire Fundamentals
| Return On Equity | 0.0533 | ||||
| Return On Asset | 0.0118 | ||||
| Profit Margin | 0.04 % | ||||
| Operating Margin | 0.07 % | ||||
| Current Valuation | 5.15 B | ||||
| Shares Outstanding | 29.97 M | ||||
| Shares Owned By Insiders | 1.94 % | ||||
| Shares Owned By Institutions | 98.06 % | ||||
| Number Of Shares Shorted | 1.95 M | ||||
| Price To Earning | 15.29 X | ||||
| Price To Book | 7.95 X | ||||
| Price To Sales | 7.38 X | ||||
| Revenue | 624.8 M | ||||
| Gross Profit | 341.74 M | ||||
| EBITDA | (40.27 M) | ||||
| Net Income | (21.15 M) | ||||
| Cash And Equivalents | 196.32 M | ||||
| Cash Per Share | 7.10 X | ||||
| Total Debt | 24.85 M | ||||
| Debt To Equity | 0.14 % | ||||
| Current Ratio | 5.62 X | ||||
| Book Value Per Share | 23.25 X | ||||
| Cash Flow From Operations | 24.65 M | ||||
| Short Ratio | 5.07 X | ||||
| Earnings Per Share | 1.11 X | ||||
| Price To Earnings To Growth | (2.57) X | ||||
| Target Price | 239.87 | ||||
| Number Of Employees | 1.01 K | ||||
| Beta | 1.36 | ||||
| Market Capitalization | 5.58 B | ||||
| Total Asset | 676.81 M | ||||
| Retained Earnings | (345.42 M) | ||||
| Working Capital | 515.63 M | ||||
| Current Asset | 167.55 M | ||||
| Current Liabilities | 64.84 M | ||||
| Net Asset | 676.81 M |
About Inspire Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Inspire Medical Systems's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Inspire Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Inspire Medical Systems based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Inspire Medical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Inspire Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inspire Medical will appreciate offsetting losses from the drop in the long position's value.Moving against Inspire Stock
| 0.69 | DXCM | DexCom Inc | PairCorr |
| 0.6 | LH | Laboratory | PairCorr |
| 0.57 | VREX | Varex Imaging Corp | PairCorr |
| 0.55 | GH | Guardant Health | PairCorr |
| 0.46 | EW | Edwards Lifesciences Corp | PairCorr |
The ability to find closely correlated positions to Inspire Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Inspire Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Inspire Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Inspire Medical Systems to buy it.
The correlation of Inspire Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Inspire Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Inspire Medical Systems moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Inspire Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Inspire Stock Analysis
When running Inspire Medical's price analysis, check to measure Inspire Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inspire Medical is operating at the current time. Most of Inspire Medical's value examination focuses on studying past and present price action to predict the probability of Inspire Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inspire Medical's price. Additionally, you may evaluate how the addition of Inspire Medical to your portfolios can decrease your overall portfolio volatility.